YOKNEAM, Israel, November 11, 2026 - InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter of 2026.
Third Quarter 2026 Highlights:
● Quarterly GAAP revenues of $92.1 million, broadly in line with the third quarter of 2025.
● Quarterly revenues from consumables and service of $19.3 million, a decrease of 3% compared to the third quarter of 2025.
● GAAP operating income of $17.5 million and *non-GAAP operating income of $20.5 million.
● Total cash position of $512.7 million as of September 30, 2026, including cash and cash equivalents, marketable securities and short-term bank deposits.
● Successful initial launch of Morpheus8 Max, with continued growth anticipated.
U.S.
